Page last updated: 2024-08-21

thiazolidines and Dry Eye Syndromes

thiazolidines has been researched along with Dry Eye Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Duan, T; Koprivica, V; Lee, S; Levin, MH; Pasricha, ND; Schallhorn, JM; Verkman, AS; Zhang, T	1

Other Studies

1 other study(ies) available for thiazolidines and Dry Eye Syndromes

Article	Year
Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2020, Volume: 36, Issue:3 Topics: Administration, Topical; Animals; Benzoates; Cautery; Chloride Channels; Corneal Injuries; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Dry Eye Syndromes; Female; Lacrimal Apparatus; Lissamine Green Dyes; Mice; Mice, Inbred BALB C; Nanotechnology; Tears; Thiazolidines; Treatment Outcome; Triazines	2020

Article

Year

Nanomolar Potency Aminophenyltriazine CFTR Activator Reverses Corneal Epithelial Injury in a Mouse Model of Dry Eye.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2020, Volume: 36, Issue:3

Topics: Administration, Topical; Animals; Benzoates; Cautery; Chloride Channels; Corneal Injuries; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Dry Eye Syndromes; Female; Lacrimal Apparatus; Lissamine Green Dyes; Mice; Mice, Inbred BALB C; Nanotechnology; Tears; Thiazolidines; Treatment Outcome; Triazines

2020